Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesComplement Inhibitor Eculizumab in Atypical Hemolytic Uremic Syndrome
Clinical Journal of the American Society of Nephrology, 08/06/09
Mache CJ et al. – In this patient, complement inhibition by eculizumab temporarily terminated the microangiopathic hemolytic activity. Nevertheless, renal damage as a result of preceding and subsequent aHUS activity resulted in end–stage renal failure; therefore, therapeutic success may depend on early administration of eculizumab. The optimal duration of treatment may be variable and remains to be determined.
Related Articles
Severe atypical HUS caused by CFH S1191L--case presentation and review of treatment options
Pediatric Nephrology, 11/04/09
Relevance Score: 85%
Maintenance of Kidney Function Following Treatment With Eculizumab and Discontinuation of Plasma Exchange After a Third Kidney Transplant for Atypical Hemolytic Uremic Syndrome Associated With a CFH Mutation
American Journal of Kidney Diseases, 10/29/09
Relevance Score: 83%
Today in Pediatric Nephrology...keeping you current
Receive free subspecialty "5-minute updates" via email
The heat shock protein profile in children with chronic kidney disease
Peritoneal Dialysis International, 03/16/10
Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome
British Journal of Clinical Pharmacology, 03/15/10
Mobilization and Collection of Peripheral Blood Stem Cells: Guidelines for Blood Volume to Process, Based on CD34-Positive Blood Cell Count in Adults and Children
Transplantation Proceedings, 03/15/10
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy of Rosuvastatin Among Men and Women With Moderate Chronic Kidney Disease and Elevated High-Sensitivity C-Reactive Protein
JACC - Journal of the American College of Cardiology, 03/16/10
Results of the Conversion to Everolimus in Renal Transplant Recipients With Posttransplantation Malignancies
Transplantation Proceedings, 03/15/10
Everolimus Versus Azathioprine in a Cyclosporine and Ketoconazole–Based Immunosuppressive Therapy in Kidney Transplant: 3-Year Follow-up of an Open-Label, Prospective, Cohort, Comparative Clinical Trial
Transplantation Proceedings, 03/15/10
Article Search
Sponsor